Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.

Description

Sci-Bot is an innovative research assistant powered by artificial intelligence, leveraging the resources of Sci-Hub to address user inquiries by directly exploring and analyzing scientific literature rather than relying on generalized training data. The system operates by meticulously scanning an extensive collection of full-text academic publications, extracting pertinent information to formulate responses that are firmly rooted in existing research, often providing citations and links to the original works. Users interact with Sci-Bot through an intuitive interface that accommodates multiple languages, as the system automatically identifies relevant keywords, retrieves scholarly articles, and organizes the information into coherent responses. Mirroring the methodology of a human researcher, it engages in a systematic approach that displays intermediate searches and sources prior to presenting a conclusive answer. By prioritizing the use of established scientific literature over generative outputs, Sci-Bot aims to minimize inaccuracies, while also facilitating direct access to complete documents, ensuring that users can verify and explore the original studies themselves. This approach not only enhances the reliability of the information provided but also encourages a deeper engagement with academic research.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

Free
Free Trial No 
Free Version Yes 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) No 
In Person No 

Vendor Details

Company Name

BenevolentAI

Founded

2013

Country

Luxembourg

Website

www.benevolent.com

Vendor Details

Company Name

Sci-Bot

Country

United States

Website

sci-bot.ru/

Product Features

Alternatives

Alternatives

LeapSpace Reviews

LeapSpace

Elsevier
Charlie Reviews

Charlie

Emerit Science